SanaClis
- Company typePrivate
- Founded2000
- HeadquartersBratislava
- Headcount101–250
- GTM typeB2B
- OfferingServices
SanaClis firmographics
Firmographics- Name
- SanaClis
- Legal name
- SanaClis s.r.o.
- Website
- https://sanaclis.eu
- Company type
- Private
- Founded year
- 2000
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
SanaClis industry classification
Industry- Product category
- Contract Research Organization Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Clinical Data Management, Biostatistics & Statistical Programming CROs (HLAGAAAF), Medical Writing & Regulatory Submission Support CROs (HLAGAAAG), Pharmacovigilance, Risk Management & Medical Affairs CROs (HLAGAAAH), Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
Keywords
Where SanaClis is headquartered
LocationHeadquarters
- HQ city
- Bratislava
Markets served
SanaClis business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- CRO Services: Full-service Contract Research Organization services including clinical monitoring, project management, regulatory services, medical writing, pharmacovigilance, medical monitoring, data management, biostatistics, site management, and decentralized trials. Revenue is generated through service contracts with pharmaceutical, biotechnology, and medical device companies for clinical trial management.
- Clinical Supply Chain Services: Integrated clinical supply chain services including global strategic sourcing, supply chain quotation, qualified person services, storage and distribution, secondary packaging and labelling, customs clearance and brokerage, and direct-to-patient services. Revenue derived from logistics and supply chain management fees.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels7 records
SanaClis product offering
Product offeringCore offering
SanaClis is a global full-service Contract Research Organization (CRO) that delivers end-to-end clinical trial services combined with integrated clinical supply chain management for pharmaceutical, biotechnology, and medical device sponsors. The company operates GMP- and GDP-certified clinical trial storage and distribution depots worldwide, manages investigational medicinal product logistics, and provides clinical operations, regulatory, pharmacovigilance, data management, and biostatistics support under both full-service and Functional Service Provider (FSP) collaboration models.
Product overview
SanaClis is a global full-service Contract Research Organization (CRO) founded in 2000, offering a unified platform of integrated clinical research and supply chain services. The company's portfolio comprises two core product lines: CRO Services (encompassing quality management, project management, clinical monitoring, regulatory services, medical writing, pharmacovigilance, medical monitoring, data management, biostatistics, site management, and decentralized trials) and Clinical Supply Chain Services (including global strategic sourcing, SIMS management system, supply chain quotation, qualified person services, storage and distribution, secondary packaging and labelling, customs clearance, and direct-to-patient services). The company operates both as a traditional full-service CRO and under a Functional Service Provider (FSP) model, serving pharmaceutical, biotechnology, and medical device companies across specialized sectors including cell and gene therapies, medical devices, biosimilars, and general biotech/pharma. SanaClis maintains an integrated approach where the CRO Services and Clinical Supply Chain Services work together end-to-end across all phases of clinical development.
Differentiator
Problem solved
Functional benefit
Products and services
- CRO Services Full-service Contract Research Organization offerings covering the entire clinical trial lifecycle including quality management, project management, clinical monitoring, regulatory services, medical writing, pharmacovigilance, medical monitoring, data management, biostatistics, site management, and decentralized trials, delivered to pharmaceutical, biotechnology, and medical device sponsors.
- Clinical Supply Chain Services Integrated clinical supply chain solutions including global strategic sourcing, supply chain quotation, qualified person services, storage and distribution, secondary packaging and labelling, customs clearance and brokerage, and direct-to-patient services for investigational medicinal products.
- Functional Service Provider (FSP) Model Flexible collaboration model that allows sponsors to scale resources and tailor support according to the specific needs of each clinical program, operating alongside the full-service CRO offering.
- SIMS (SanaClis Interactive Management System) Proprietary online access platform for clinical supply chain management, providing clients with portal-based interactive tools to manage trial logistics, inventory, and supply chain operations.
Quantifiable outcome
- 93% of studies finished ahead of schedule and budget
- +2 more outcomes
Companies that use SanaClis
Customer profileSegments4 records
Ideal customer profiles4 records
SanaClis technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
SanaClis partnerships and signals
Strategic signalScale indicators5 records
Recent moves5 records
Expansion highlights4 records
SanaClis competitors and assessment
Company assessmentDirect peers
- Medpace: Mid-to-large full-service CRO with deep scientific/therapeutic-area expertise and an owner-operator model closely analogous to SanaClis' positioning, serving similar biotech through mid-pharma sponsors.
- Parexel International: Privately held global full-service CRO covering the same clinical operations, regulatory, biostatistics, and pharmacovigilance service lines as SanaClis, competing for the same enterprise pharma programs.
- Fortrea (former LabCorp/Covance Clinical Development): Pure-play clinical CRO spun out of LabCorp, offering full-service clinical operations alongside central lab testing — directly competitive on the same CRO-services RFPs and adjacent to SanaClis' supply chain offering.
- ICON plc: Top-tier global full-service CRO with comparable breadth across clinical operations, biostatistics, regulatory, and laboratory services. Direct competitor for the same pharma and biotech sponsor RFPs that SanaClis targets.
- Syneos Health: Global full-service CRO with clinical and commercial capabilities, competing head-to-head for biotech and pharma study awards across all phases.
- Worldwide Clinical Trials: Mid-sized, PE-backed full-service CRO with comparable therapeutic-area expertise and pharma/biotech client mix — the closest size-and-model analogue to SanaClis in the market.
Broad incumbents
- IQVIA: The largest global full-service CRO and clinical technology provider. Comparable because it offers end-to-end clinical trial services plus adjacent data/technology capabilities that SanaClis also targets, albeit at vastly greater scale.
- Eurofins Central Laboratory: Global central and specialty laboratory provider for clinical trials. Adjacent to SanaClis' supply chain and trial services where laboratory testing intersects with clinical operations, though Eurofins does not provide the broader CRO suite.
- Charles River Laboratories: Diversified CRO with preclinical discovery plus clinical and manufacturing services. Comparable as an established incumbent capturing outsourced R&D spend, though SanaClis does not compete in its preclinical franchise.
Emerging players
- Tigermed: Leading China-based full-service CRO with growing international presence, increasingly competing in Europe on biotech trials — a relevant emerging peer for SanaClis' global sponsor pitches.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
SanaClis social profiles
Digital presenceSanaClis compliance and trust
Trust signalCompliance2 records
SanaClis financial estimates
Financial estimateRevenue estimate
Valuation estimate
SanaClis leadership team
Management profileNumber of profiles
Profiles1 record
SanaClis funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
SanaClis M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about SanaClis
What does SanaClis do?
SanaClis is a global full-service Contract Research Organization (CRO) that delivers end-to-end clinical trial services combined with integrated clinical supply chain management for pharmaceutical, biotechnology, and medical device sponsors. The company operates GMP- and GDP-certified clinical trial storage and distribution depots worldwide, manages investigational medicinal product logistics, and provides clinical operations, regulatory, pharmacovigilance, data management, and biostatistics support under both full-service and Functional Service Provider (FSP) collaboration models.
Is SanaClis a public or private company?
SanaClis is a private company. It is classified as unknown and is currently operating.
When was SanaClis founded?
SanaClis was founded in 2000. It employs 101 to 250 people.
Where is SanaClis based?
SanaClis is headquartered in Bratislava.
How does SanaClis make money?
Two revenue lines are on record. CRO Services are the primary driver. The others are clinical Supply Chain Services.
Who are SanaClis's main competitors?
Direct peers on record are Medpace, Parexel International, Fortrea (former LabCorp/Covance Clinical Development), ICON plc, Syneos Health and Worldwide Clinical Trials. Broad incumbents are IQVIA, Eurofins Central Laboratory and Charles River Laboratories. Tigermed is listed as an emerging player.
Does SanaClis have an API?
No public API is recorded for SanaClis.
What industry is SanaClis in?
SanaClis's product category is Contract Research Organization Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAF, Clinical Data Management, Biostatistics & Statistical Programming CROs. Its NAICS code is 54171 and its SIC code is 8731.